Population
162 plasma samples from Country Brandenburg Hospital in Bernau with CRP concentration between 0.03 and 283.2…
Comparison
Novel 'digital-style' semiquantitative lateral… vs In-house enzyme-linked immunosorbent assay (ELISA)
Design
Other
Authors
Loading...
Supports point-of-care assay development for AMI and CVD risk; leaves open clinical validation and outcome studies.
A novel 'digital-style' lateral flow assay for H-FABP and CRP showed good agreement with ELISA, offering a simple, rapid tool for AMI detection and CVD risk prediction.
Leung et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: